CareSource Reminds West Virginia Consumers of Upcoming Deadlines
/
Date12 Dec 2016
DAYTON, Ohio, Dec. 12, 2016 (GLOBE NEWSWIRE) — CareSource, a nonprofit health plan, reminds consumers to enroll in a Marketplace plan before the December 15... Read More →
Elbit Imaging Ltd. Announces That Gamida Cell’s Phase 3 Study of NiCord for Blood Cancers is Now Enrolling
/
Date12 Dec 2016
TEL AVIV, Israel, Dec. 12, 2016 (GLOBE NEWSWIRE) — Elbit Imaging Ltd. (TASE:EMITF) (NASDAQ:EMITF) (“Elbit” or the “Company“) announced today that it was informed by Gamida Cell... Read More →
Immunomedics Announces Novel Immuno-Oncology Program Targeting Trop-2-Expressing Cancers
/
Date12 Dec 2016
— Preclinical Studies Presented at 2016 San Antonio Breast Cancer Symposium (SABCS) —— Updated Phase 2 Results with Sacituzumab Govitecan (IMMU-132) in Metastatic Triple-Negative Breast... Read More →
SHOULDER INNOVATIONS LAUNCHES SIMPLE, INNOVATIVE TOTAL SHOULDER REPLACEMENT SYSTEM
/
Date12 Dec 2016
Shoulder Innovations Clinical HOLLAND, Mich., Dec. 12, 2016 (GLOBE NEWSWIRE) — Shoulder Innovations, an emerging developer of shoulder replacement systems, today announced the commercial release... Read More →
Global Cancer Drugs Market expected to reach USD 161.30 Billion by 2021: Zion Market Research
/
Date12 Dec 2016
Sarasota, FL, Dec. 12, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy,... Read More →
BioMarin Enrolls First Participant in Phase 3 Trial of Vosoritide for Treatment of Children with Achondroplasia
/
Date12 Dec 2016
SAN RAFAEL, Calif., Dec. 12, 2016 (GLOBE NEWSWIRE) — BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the company has initiated a global Phase 3 study... Read More →
Novo Nordisk A/S – aktietilbagekøbsprogram
/
Date12 Dec 2016
Selskabsmeddelese nr. 87 / 2016.pdf Bagsværd, 2016-12-12 – Den 28. oktober 2016 iværksatte Novo Nordisk et aktietilbagekøbsprogram i overensstemmelse med artikel 5 i Europa-Parlamentet og... Read More →
Novo Nordisk A/S – Share repurchase programme
/
Date12 Dec 2016
Company Announcement No 87 /2016.pdf Bagsværd, Denmark, 12 December 2016 – On 28 October 2016, Novo Nordisk initiated a share repurchase programme in accordance with... Read More →
Diffusion Pharmaceuticals Files Definitive Proxy Statement for Upcoming Special Meeting of Stockholders
/
Date12 Dec 2016
CHARLOTTESVILLE, Va., Dec. 12, 2016 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule... Read More →
RedHill Biopharma Announces Phase IIa 48-Week Final Results Further Supporting Potential of RHB-104 in Multiple Sclerosis
/
Date12 Dec 2016
Thought to be autoimmune in nature, the multiple sclerosis (MS) inflammatory process is also consistent with an infectious disease; The CEASE-MS Phase IIa proof-of-concept (PoC),... Read More →